First Department of Medicine, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
DZHK (German Center for Cardiovascular Research) Partner Site, Mannheim, Germany.
Dis Markers. 2017;2017:9306409. doi: 10.1155/2017/9306409. Epub 2017 Jul 18.
This study evaluates the association between high sensitivity troponin I (hsTnI) and T (hsTnT) and the morphology of coronary artery plaques detected by coronary computed tomography angiography (CCTA) in patients with suspected coronary artery disease (CAD).
Patients undergoing CCTA were prospectively enrolled. CCTA was indicated by a low to intermediate pretest probability for CAD during routine clinical care. Within 24 hours of CCTA examination, peripheral blood samples were taken to measure hsTnI, hsTnT, and N-terminal probrain natriuretic peptide (NT-proBNP).
A total of 99 patients were enrolled with 43% without CAD, 9% with noncalcified plaques, 28% with calcified plaques, and 19% with mixed type plaque lesions. Both hsTnI and hsTnT levels were able to discriminate significantly between the groups, especially in the presence of mixed coronary plaques (AUC range: 0.741-0.752; = 0.0001). In multivariate logistic regression models, hsTnT, but not hsTnI, was still significantly associated with mixed coronary plaque morphology (odds ratio = 8.968; 95% CI 1.999-40.241; = 0.004).
Both hsTnI and hsTnT are able to discriminate between different coronary artery plaques morphologies, whereas hsTnT was significantly associated with mixed coronary plaques in patients with suspected CAD. This trial is registered with NCT03074253.
本研究评估了在疑似冠心病(CAD)患者中,高敏肌钙蛋白 I(hsTnI)和 T(hsTnT)与冠状动脉计算机断层扫描血管造影(CCTA)检测到的冠状动脉斑块形态之间的关系。
前瞻性纳入接受 CCTA 的患者。CCTA 是在常规临床护理中 CAD 低至中度的术前概率指征下进行的。在 CCTA 检查后 24 小时内,采集外周血样以测量 hsTnI、hsTnT 和 N 端脑利钠肽前体(NT-proBNP)。
共纳入 99 例患者,其中 43%无 CAD,9%为非钙化斑块,28%为钙化斑块,19%为混合斑块病变。hsTnI 和 hsTnT 水平均能显著区分各组,尤其是在存在混合性冠状动脉斑块时(AUC 范围:0.741-0.752;P=0.0001)。在多变量逻辑回归模型中,hsTnT 而不是 hsTnI 与混合性冠状动脉斑块形态仍显著相关(比值比=8.968;95%置信区间 1.999-40.241;P=0.004)。
hsTnI 和 hsTnT 均能区分不同的冠状动脉斑块形态,而 hsTnT 与疑似 CAD 患者的混合性冠状动脉斑块显著相关。本试验已在 NCT03074253 注册。